Considine RV, Sinha MK, Heiman ML, et al. 1996. Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med, 334:292-5. Correia ML, Haynes WG, Rahmouni K, et al. 2002. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes, 51:439-42. Echtenkamp SF, Dandridge PF. 1989. Influence of renal sympathetic nerve stimulation on renal function in the primate. Am J Physiol, 257:F204-9. El-Gharbawy AH, Kotchen JM, Grim CE, et al. 2002. Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans. Am J Hypertens, 15:989-93. Ficek J, Kokot F, Chudek J, et al. 2002. Influence of antihypertensive treatment with perindopril, pindolol or felodipinon plasma leptin concentration in patients with essential hypertension. Horm Metab Res, 34:703-8. Fogari R, Derosa G, Zoppi A, et al. 2005. Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Hypertens Res, 28:209-14. Fruhbeck G. 1999. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes, 48:903-8. Golan E, Tal B, Dror Y, et al. 2002. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity- related hypertension. Isr Med Assoc J, 4:426-30. Hall JE, Hildebrandt DA, Kuo J. 2001. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertension, 14(6 Pt 2):103S- 115S. Haynes WG, Morgan DA, Walsh SA, et al. 1997. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest, 100:270- 8. Haynes WG, Morgan DA, Walsh SA, et al. 1998. Cardiovascular consequences of obesity: role of leptin. Clin Exp Pharmacol Physiol, 25:65-9. Haynes WG, Sivitz WI, Morgan DA, et al. 1997. Sympathetic and cardiorenal actions of leptin. Hypertension, 30:619-23. Itoh K, Imai K, Masuda T, et al. 2002. Relationship between changes in serum leptin levels and blood pressure after weight loss. Hypertens Res, 25:881-6. Jackson EK, Li P. 1997. Human leptin has natriuretic activity in the rat. Am J Physiol, 272:F333-8. Kassab S, Kato T, Wilkins FC, et al. 1995. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension, 25:893-7. Kirchheim H, Ehmke H, Persson P. 1989. Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin Wochenschr, 67:858-64. Kunz I, Schorr U, Klaus S, et al. 2000. Resting metabolic rate and substrate use in obesity hypertension. Hypertension, 36:26-32. Lembo G, Vecchione C, Fratta L, et al. 2000. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes, 49:293-7. Masuo K, Mikami H, Ogihara T, et al. 2001. Weight reduction and pharmacologic treatment in obese hypertensives. Am J Hypertens, 14:530-8. Leptin and hypertension in obesity Mattson DL, Lu S, Nakanishi K, et al. 1994. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol, 266:H1918-26. Munzberg H, Flier JS, Bjorbaek C. 2004. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology, 145:4880-9. Ortiz PA, Garvin JL. 2002. Role of nitric oxide in the regulation of nephron transport. Am J Physiol Renal Physiol, 282:F777-84. Rahmouni K, Haynes WG, Morgan DA, et al. 2002. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension, 39:486-90. Rahmouni K, Morgan DA, Morgan GM, et al. 2005. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes, 54:2012-18. Satoh N, Ogawa Y, Katsuura G, et al. 1999. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes, 48:1787-93. Schutte R, Huisman HW, Schutte AE, et al. 2005. Leptin is independently associated with systolic blood pressure, pulse pressure and arterial compliance in hypertensive African women with increased adiposity: the POWIRS study. J Hum Hypertens, 19:535-41. Serradeil-Le Gal C, Raufaste D, Brossard G, et al. 1997. Characterization and localization of leptin receptors in the rat kidney. FEBS Lett, 404:185-91. Skurk T, van Harmelen V, Blum WF, et al. 2005. Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway. Obes Res, 13:969-73. Sonmez A, Kisa U, Uckaya G, et al. 2001. Effects of losartan treatment on T-cell activities and plasma leptin concentrations in primary hypertension. J Renin Angiotensin Aldosterone Syst, 2:112-16. Takizawa H, Ura N, Saitoh S, et al. 2001. Gender difference in the relationships among hyperleptinemia, hyperinsulinemia, and hypertension. Clin Exp Hypertens, 23:357-68. Uckaya G, Ozata M, Sonmez A, et al. 1999. Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension. Horm Metab Res, 31:435-8. Vecchione C, Maffei A, Colella S, et al. 2002. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes, 51:168-73. Villarreal D, Reams G,Freeman RH. 2000. Effects of renal denervation on the sodium excretory actions of leptin in hypertensive rats. Kidney Int, 58:989-94. Villarreal D, Reams G, Freeman RH, et al. 1998. Renal effects of leptin in normotensive, hypertensive, and obese rats. Am J Physiol, 275:R2056- 60. Villarreal D, Reams G, Samar H, et al. 2004. Effects of chronic nitric oxide inhibition on the renal excretory response to leptin. Obes Res, 12:1006-10. Vitoratos N, Chrystodoulacos G, Kouskouni E, et al. 2001. Alterations of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol, 96:59-62. Zhang R, Reisin E. 2000. Obesity-hypertension: the effects on cardiovascular and renal systems. Am J Hypertens, 13:1308-14. Vascular Health and Risk Management 2006:2(2) 169